Dr Franck Morschhauser, of Centre Hospitalier Universitaire Régional de Lille, Unité GRITA, Lille, France, discusses the question: is RELEVANCE relevant? He covers the results of the Phase III study (NCT01476787) of R2 vs R-chemo in first-line follicular lymphoma. This video was recorded at the 23rd congress of the European Hematology Association (EHA) 2018 press briefing, held in Stockholm, Sweden.
Follicular lymphoma: is RELEVANCE relevant?
